US biopharma: "nearly 300 vaccines in R&D"

Article Date: 24/04/2012 06:00
US biopharma: "nearly 300 vaccines in R&D"

Vacancy Search

Quick job search

Advanced Search

Latest News

Upcoming events: Roche PD-L1 data and FDA decisions for AbbVie and Actavis

Welcome to your weekly digest of approaching regulatory and clinical readouts. AbbVie is to receive a US decision imminently on its all oral, interferon-free, hep C combo; the company's US...

First blood treatment system in US could cut cost of transfusions

It is difficult to say how much of a role panic over this summer’s Ebola outbreak played in the FDA’s decision to approve Cerus’s blood filtration system, but it seems likely to have...
more news